Description

Pemomab Injection 100mg/4ml (Pembrolizumab) – Uses, Side Effects, Dosage & Price in Pakistan

Pemomab Injection 100mg/4ml (Pembrolizumab) is a prescription immunotherapy medicine used to treat several types of cancer. Pembrolizumab is a PD-1 blocking antibody that helps the immune system recognize and attack certain cancer cells. It may be used alone or in combination with chemotherapy, targeted medicines, or other cancer treatments depending on the type and stage of cancer.

Pemomab Injection 100mg/4ml contains pembrolizumab as an intravenous formulation. The medicine is administered by a qualified healthcare professional through an IV infusion rather than being taken orally. The current prescribing information lists pembrolizumab for a wide range of cancers, including melanoma, non-small cell lung cancer, head and neck cancer, urothelial cancer, certain colorectal cancers, gastric cancer, esophageal cancer, cervical cancer, renal cell carcinoma, hepatocellular carcinoma, and several other approved cancer indications.

For patients in Pakistan searching for information about Pemomab Injection, understanding its approved uses, dosage, side effects, precautions, and monitoring requirements is important. Impo Medic provides medicine-related information to help patients and caregivers understand prescription oncology medicines before discussing treatment with their healthcare professional.

Pemomab Injection 100mg/4ml (Pembrolizumab) Used For

Pemomab Injection may be used for several cancers when the patient’s disease meets the relevant treatment criteria. Depending on the cancer, pembrolizumab may be prescribed as a single medicine or together with other anticancer treatments.

Approved uses include certain cases of:

• Melanoma
• Non-small cell lung cancer (NSCLC)
• Head and neck squamous cell carcinoma (HNSCC)
• Urothelial cancer
• Microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancers
• Colorectal cancer with MSI-H or dMMR characteristics
• Gastric and gastroesophageal junction cancer
• Esophageal cancer
• Cervical cancer
• Hepatocellular carcinoma
• Renal cell carcinoma
• Endometrial carcinoma
• Cutaneous squamous cell carcinoma
• Merkel cell carcinoma
• Certain triple-negative breast cancers
• Primary mediastinal large B-cell lymphoma
• Classical Hodgkin lymphoma
• Other specifically defined tumors under the approved prescribing information.

The exact indication depends on the cancer type, stage, previous treatment, biomarker results, and whether pembrolizumab is being used alone or in combination with another medicine.

Melanoma

Pembrolizumab can be used for unresectable or metastatic melanoma. It is also approved as adjuvant treatment for certain adults and pediatric patients aged 12 years and older with Stage IIB, IIC, or III melanoma following complete surgical removal.

Non-Small Cell Lung Cancer

Pembrolizumab is used in several NSCLC treatment settings. Depending on the disease characteristics, it may be administered alone or combined with chemotherapy.

Some single-agent uses require specific PD-L1 expression, while combination regimens may be selected based on histology, stage, molecular findings, and previous treatment.

Urothelial Cancer

Pembrolizumab may be used for certain locally advanced or metastatic urothelial cancers. Its use can depend on previous platinum-containing treatment or eligibility for platinum chemotherapy.

MSI-H and dMMR Cancers

Pembrolizumab has important biomarker-based indications for tumors that are microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR).

Testing is therefore important when the treatment indication depends on these biomarkers.

How Pemomab Injection 100mg/4ml (Pembrolizumab) Works

Pembrolizumab is an immune checkpoint inhibitor and a programmed death receptor-1 (PD-1) blocking antibody.

Some cancer cells can use the PD-1 pathway to reduce the activity of immune cells against them. Pembrolizumab binds to PD-1 and blocks this interaction, helping restore immune-system activity against certain cancer cells.

Because pembrolizumab works by modifying immune activity rather than directly killing cancer cells like traditional cytotoxic chemotherapy, it can cause a distinctive group of immune-related adverse reactions. These reactions can affect different organs and require medical monitoring.

Pemomab Injection 100mg/4ml Dosage

The appropriate pembrolizumab dose depends on the patient’s age, weight where applicable, cancer type, treatment regimen, and clinical situation.

For many adult indications, the recommended intravenous dosing is:

• 200mg every 3 weeks, or
• 400mg every 6 weeks

Pembrolizumab is administered as an IV infusion over approximately 30 minutes after appropriate dilution.

The 100mg/4mL presentation contains pembrolizumab at a concentration of 25mg/mL in a single-dose vial. Because Pemomab 100mg/4ml is a specific vial strength, the number of vials required for a prescribed dose must be determined and prepared by healthcare professionals.

The treatment schedule can vary depending on the cancer. Some treatment courses continue until disease progression, unacceptable toxicity, recurrence, or for a specified maximum treatment duration according to the particular indication.

Patients should never attempt to calculate, dilute, or administer Pemomab Injection themselves.

How Pemomab Injection Is Given

Pemomab Injection 100mg/4ml is given through an intravenous infusion in a healthcare facility.

Before and during treatment, the healthcare team may monitor:

• Liver function
• Kidney function
• Thyroid function
• Blood counts
• Signs of immune-related complications
• Infusion reactions
• General response to treatment

The prescribing information recommends monitoring liver enzymes, creatinine, and thyroid function at baseline and periodically during treatment.

The infusion should be administered by trained healthcare professionals who can identify and manage infusion-related or immune-mediated reactions.

Pemomab Injection Side Effects

Pemomab Injection can cause side effects. Because pembrolizumab activates immune responses, some adverse reactions are related to immune-system activity.

Common or clinically reported adverse effects can include:

• Fatigue
• Weakness
• Rash
• Itching
• Diarrhea
• Nausea
• Reduced appetite
• Constipation
• Cough
• Shortness of breath
• Fever
• Joint pain
• Muscle pain
• Infusion-related reactions

The exact side effects and their frequency can vary depending on the cancer being treated and whether pembrolizumab is combined with chemotherapy or another medicine.

Patients should tell their healthcare team about new, persistent, or worsening symptoms rather than stopping treatment independently.

Serious Side Effects and Warnings

One of the most important features of pembrolizumab treatment is the possibility of immune-mediated adverse reactions. These reactions can potentially affect almost any organ or body system and can sometimes be severe or life-threatening.

Immune-Mediated Pneumonitis

Pembrolizumab can cause inflammation of the lungs called pneumonitis.

Possible symptoms include:

• New or worsening cough
• Shortness of breath
• Chest discomfort
• Reduced exercise tolerance

These symptoms should be reported promptly because pneumonitis may require treatment interruption and medical management.

Immune-Mediated Colitis

Inflammation of the bowel can occur during treatment.

Possible warning signs include:

• Persistent diarrhea
• Abdominal pain
• Blood or mucus in stool
• Increased bowel movements

Severe diarrhea should not be ignored.

Immune-Mediated Hepatitis

Pembrolizumab can cause inflammation of the liver.

Possible symptoms include:

• Yellowing of the skin or eyes
• Dark urine
• Abdominal discomfort
• Unusual tiredness
• Loss of appetite

Liver blood tests are important during treatment because liver inflammation may sometimes develop before noticeable symptoms.

Endocrine Problems

Pembrolizumab can affect hormone-producing glands, including the thyroid and pituitary glands.

Patients may experience symptoms such as:

• Unusual tiredness
• Weight changes
• Headache
• Dizziness
• Changes in heart rate
• Temperature sensitivity

Thyroid and other endocrine tests may be required during treatment.

Kidney Problems

Immune-mediated nephritis can cause kidney inflammation and impaired kidney function. Creatinine monitoring is recommended during therapy.

Skin Reactions

Immune-mediated dermatologic reactions may occur. Patients should report severe or rapidly worsening rash, blistering, skin peeling, or other unusual skin changes.

Infusion-Related Reactions

Some patients may develop reactions during or after the infusion. Symptoms can include:

• Fever
• Chills
• Flushing
• Dizziness
• Breathing difficulty
• Rash
• Low blood pressure

Healthcare professionals can slow, interrupt, or discontinue the infusion depending on the severity of the reaction.

Precautions Before Using Pemomab Injection

Before receiving Pemomab Injection 100mg/4ml, tell your healthcare provider about your complete medical history.

Particular attention may be required if you have:

• Previous autoimmune disease
• Lung disease
• Liver disease
• Kidney disease
• Thyroid or other endocrine disorders
• Previous organ transplantation
• Previous severe reaction to immunotherapy
• Current or previous immune-suppressing treatment
• Pregnancy or plans to become pregnant

Your doctor should also know about previous cancer treatments and all medicines you currently use.

Patients who have received or may receive an allogeneic hematopoietic stem-cell transplant require particular medical consideration because serious complications can occur in connection with PD-1 blocking therapy.

Pemomab Injection Drug Interactions

Pembrolizumab does not have the same conventional drug-interaction profile as many small-molecule medicines, but the patient’s complete treatment regimen still needs to be reviewed.

Tell your doctor about:

• Prescription medicines
• Over-the-counter medicines
• Corticosteroids
• Immunosuppressive medicines
• Vitamins
• Herbal supplements
• Other cancer medicines

Do not start, stop, or change another medicine without discussing it with the treating healthcare professional.

Special consideration may be needed when immune-suppressing treatment is required to manage immune-mediated adverse reactions.

Pemomab Injection During Pregnancy

Pembrolizumab can cause fetal harm. Women who can become pregnant should discuss pregnancy prevention with their healthcare professional before starting treatment.

Patients should inform their doctor immediately if they become pregnant during treatment or believe they may be pregnant.

The healthcare professional can provide individualized advice regarding contraception, pregnancy, and breastfeeding based on the treatment plan.

Pemomab Injection Storage

Pemomab Injection should be handled and stored according to the manufacturer’s product information and professional pharmacy requirements.

The medicine should remain under appropriate controlled storage conditions until it is prepared for administration.

Healthcare facilities should follow the product-specific instructions for:

• Refrigeration
• Protection from light
• Preparation
• Dilution
• Handling
• Infusion

Patients should not attempt to store, dilute, or prepare the injection for self-administration.

Pemomab Injection 100mg/4ml Price in Pakistan

The price of Pemomab Injection 100mg/4ml in Pakistan may vary according to the manufacturer, supplier, availability, import conditions, and market changes.

Specialized oncology medicines can have different prices between suppliers, so patients should confirm the current price and availability before purchasing.

For Pakistan-based medicine information and availability, patients can contact Impo Medic to check the latest product details.

When purchasing Pemomab Injection, it is important to verify the exact strength, packaging, manufacturer, batch information, expiry date, and storage conditions.

How to Buy Pemomab Injection 100mg/4ml in Pakistan

Patients looking to buy Pemomab Injection 100mg/4ml in Pakistan should obtain it through a reliable medicine supplier and according to a valid prescription.

Before purchasing, confirm:

• Product name
• Pembrolizumab strength
• 100mg/4mL vial presentation
• Manufacturer
• Batch number
• Expiry date
• Packaging condition
• Proper storage and handling

Impo Medic can be contacted for information regarding Pemomab Injection availability in Pakistan.

Because pembrolizumab is an intravenous oncology medicine, it should only be prepared and administered by trained healthcare professionals.

Frequently Asked Questions About Pemomab Injection 100mg/4ml (Pembrolizumab)

What is Pemomab Injection 100mg/4ml (Pembrolizumab) used for?

Pemomab Injection contains pembrolizumab, a PD-1 blocking immunotherapy used for several approved cancer indications, including certain melanoma, lung, urothelial, head and neck, colorectal, gastric, esophageal, cervical, renal, liver, and other cancers. The exact indication depends on cancer type and relevant clinical or biomarker criteria.

Is Pemomab Injection a chemotherapy medicine?

Pembrolizumab is an immunotherapy and immune checkpoint inhibitor, not a traditional cytotoxic chemotherapy medicine. It may nevertheless be administered together with chemotherapy in some cancer treatment regimens.

How is Pemomab Injection administered?

Pemomab Injection is administered intravenously by a qualified healthcare professional. Pembrolizumab is generally infused over approximately 30 minutes after dilution.

What is the usual pembrolizumab dose?

For many adult indications, pembrolizumab is given as 200mg every 3 weeks or 400mg every 6 weeks. The exact regimen depends on the approved indication and the patient’s treatment plan.

What are the major side effects of Pemomab Injection?

Possible side effects include fatigue, rash, itching, diarrhea, nausea, reduced appetite, cough, shortness of breath, joint pain, muscle pain, and infusion-related reactions. Pembrolizumab can also cause serious immune-mediated reactions affecting organs such as the lungs, liver, bowel, kidneys, skin, and endocrine glands.

Can Pemomab Injection affect the liver?

Yes. Pembrolizumab can cause immune-mediated hepatitis. Liver enzymes should be monitored during treatment, and symptoms such as yellow skin or eyes, dark urine, severe fatigue, or abdominal discomfort should be reported promptly.

Can Pemomab Injection cause diarrhea?

Yes. Diarrhea can occur and may sometimes indicate immune-mediated colitis. Persistent or severe diarrhea should be reported to the treating healthcare professional.

Is Pemomab Injection safe during pregnancy?

Pembrolizumab can cause fetal harm. Women who can become pregnant should discuss effective contraception and pregnancy-related risks with their healthcare professional before treatment.

Does Pemomab Injection require laboratory monitoring?

Yes. Depending on the treatment plan, doctors may monitor liver enzymes, kidney function, thyroid function, blood counts, and other clinical parameters during treatment.

Is Pemomab Injection 100mg/4ml available in Pakistan?

Availability can vary between suppliers and pharmacies in Pakistan. Patients can contact Impo Medic to check current availability and product information.